Current Clinical Guidance

Filter Standards and Guidance documents

CEU Statement - Intravascular insertion of Nexplanon® - June 2016

This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD to healthcare professionals in the UK regarding a small number of reports of Nexplanon contraceptive implants inadvertently inserted into blood vessels.

This document is up-to-date

CEU Guidance Quick Starting Contraception Sept 2010

This guidance is intended for use by health professionals providing contraception in any setting within the UK. Recommendations are based on available evidence and consensus opinion of experts.

This document is up-to-date

CEU Statement Quick Starting After UPA - Sept 2015

Faculty of Sexual and Reproductive Healthcare (FSRH) response to new data on quickstarting hormonal contraception after use of ulipristal acetate 30mg (ellaOne®) for emergency contraception Sept 2015.

This document is up-to-date

CEU Guidance Problematic Bleeding with Hormonal Contraception Jul 2015

This guidance brings together evidence and expert opinion on the management of problematic bleeding in women using hormonal contraception [i.e. the combined oral contraceptive pill (COC), transdermal patch, combined vaginal ring (CVR), progestogen-only pill (POP), progestogen-only injectable, progestogen-only implant or intrauterine system (IUS)].

This document is up-to-date

CEU Guidance Fertility Awareness Methods - June 2015

This is a new guidance document that provides evidence-based recommendations and good practice points on the use of fertility awareness methods (FAM) for the purpose of preventing and/or spacing pregnancies. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

CEU Guidance Intrauterine Contraception April 2015

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of intrauterine contraception (IUC) currently available in the UK. Intrauterine methods include copper intrauterine devices (Cu-IUDs) and levonorgestrel intrauterine systems (LNG-IUS).

This document is up-to-date

CEU Guidance Progestogen Only Pills March 2015

This guidance provides evidence-based recommendations and good practice points on use of the progestogen-only pill (POP). It is intended for any health professional or service providing contraception or contraceptive advice in the UK.

This document is up-to-date

CEU Guidance Progestogen-only Injectables Dec 2014

This document provides clinical guidance, evidence-based recommendations and good practice points on use of progestogen-only injectable contraception. Unless otherwise stated, the guidance will refer to depot medroxyprogesterone acetate (DMPA) injectable contraception. Information on norethisterone enantate (NET-EN) will be included where relevant.

This document is up-to-date

CEU Statement Venous Thromboembolism

The BMJ today publishes the findings of a large UK observational study by Vinogradova et al looking at the association between combined oral contraception (COC) and risk of venous thromboembolism (VTE) May 2015.

This document is up-to-date

CEU Guidance Male Female Sterilisation CPD Sep 2014

This document provides clinical guidance on elective male sterilisation (vasectomy) and female sterilisation (tubal occlusion). It is intended for any health professional or service that undertakes vasectomy and/or tubal occlusion in the UK as well as those who refer individuals for either procedure.

This document is up-to-date

CEU Guidance Male and Female Sterilisation Summary of Recommendations Sep 2014

UK clinical guidance on Male and Female Sterilisation was last published by the Royal College of Obstetricians and Gynaecologists (RCOG) in 2004. Updated guidance has been published by the Clinical Effectiveness Unit (CEU) of the Faculty of Sexual & Reproductive Healthcare (FSRH) under an agreed arrangement with the RCOG.

This document is up-to-date